Table 1.
VIT D < 25 nmol/L (Total =12) N (%) |
VIT D ≥ 25 nmol/L (Total = 97) N (%) |
p Value | |
---|---|---|---|
Age (liver surgery) | 60 ± 11 | 66 ± 12 | 0.09 |
Gender | 0.15 | ||
Male | 3 (25%) | 44 (45.5%) | |
Female | 9 (75%) | 53 (54.5%) | |
BMI | 27.5 ± 3.6 | 26.4 ± 4.8 | 0.54 |
T | 0.13 | ||
1 | 1 (8.3%) | 2 (2%) | |
2 | 3 (25%) | 6 (6.2%) | |
3 | 6 (50%) | 60 (61.8%) | |
4 | 1(8.3%) | 9 (9.3%) | |
unknown | 1 (8.3%) | 20 (20.5%) | |
N | 0.82 | ||
N0 | 5 (41.7%) | 32 (33%) | |
N1 | 5 (41.7) | 29 (29.9%) | |
N2 | 1 (8.3%) | 16 (16.5%) | |
unknown | 1 (8.3%) | 20 (20.6%) | |
DFS (liver mets) | 0.82 | ||
<12 months | 6 (50%) | 51 (52.6%) | |
≥12 months | 5 (41.7%) | 37 (38.1%) | |
unknown | 1 (8.3%) | 9 (9.3%) | |
Clinical risk factor (Fong) | 0.59 | ||
0–2 | 8 (66.7%) | 67 (69.1%) | |
3–5 | 3 (25%) | 17 (17.5%) | |
Unknown | 1 (8.3%) | 13 (13.4%) | |
Size of largest liver tumor | 0.37 | ||
<5 cm | 10 (83.3%) | 85 (87.6%) | |
≥5 cm | 2 (16.7%) | 8 (8.2%) | |
Unknown | 4 (4.2%) | ||
Number of liver metastases | 0.75 | ||
1 | 7 (58.3%) | 57 (58.8%) | |
>1 | 5 (41.7%) | 40 (41.2%) | |
Peri-operative chemotherapy | 0.92 | ||
Yes | 9 (75%) | 71 (73.2%) | |
No | 3 (25%) | 26 (26.8%) | |
Blood transfusion | 0.011 | ||
Yes | 4 (33.3%) | 10 (10.3%) | |
No | 5 (41.7%) | 72 (74.2%) | |
Unknown | 3 (25%) | 15 (15.5%) | |
Liver resection | 0.17 | ||
Anatomic | 3 (25%) | 12 (12.4%) | |
Non-anatomic | 9 (75%) | 85 (87.6%) | |
Sequence of resection | 0.97 | ||
Liver first | 1 (8.3%) | 9 (9.3%) | |
Colon first | 9 (75%) | 72 (72.2%) | |
Combined | 2 (16.7%) | 18 (18.6%) | |
Complication: total | 0.009 | ||
Yes | 6 (50%) | 17 (17.5%) | |
No | 6 (50%) | 19 (82.5%) | |
Complication: infection | 0.04 | ||
Yes | 3 (25%) | 7 (7.2%) | |
No | 9 (75%) | 90 (92.8%) |